-
公开(公告)号:DE3006351A1
公开(公告)日:1981-09-17
申请号:DE3006351
申请日:1980-02-20
Applicant: BASF AG
Inventor: SCHLECKER RAINER DIPL CHEM DR , FRANKE ALBRECHT DIPL CHEM DR , THIEME PETER C DIPL CHEM DR , FRICKEL FRITZ-FRIEDER DIPL CHE , LENKE DIETER PROF DR , GRIES JOSEF DR MED
IPC: C07D213/30 , C07D271/06 , C07D271/10 , C07D275/02 , C07D277/24 , C07D307/42 , C07D333/16 , C07F9/58 , C07F9/653 , C07F9/6539 , C07F9/655 , C07F9/6553 , C07D271/02 , A61K31/34 , A61K31/38 , A61K31/42 , A61K31/425 , A61K31/44 , C07D213/24 , C07D283/00
Abstract: 2-((3-amimo-2-hydroxypropoxy)-styryl) derivs. of formula (I) and their physiologically acceptable salts are new. (where Het is 2-furyl, 2- or 3-thienyl, 2- or 4-pyridyl, 4-thiazolyl, 4-isothiazolyl, 5-(1,2,4-oxadiazolyl) or 5-(1,3,4-oxadiazolyl), all these gps. opt. substd. by 1-4C alkyl or Ph which is itself opt. mono or disubstd by 1-3C alkyl; R is H, 1-8C alkyl (opt. substd. by OH, 1-3C alkoxy or 1-3C alkyl or 3-8 ring C cycloalkyl), 3-8 ring C cycloalkyl, opt. mono or disubstd. on the ring with 1-3C alkyl). (I) are pharmaceuticals for the treatment of hypertonia, coronary heart disease or cardiac arhythm. (I) are beta-sympatholytics which can be used in doses 15-23 times smaller than doses necessary if a similar effect is to be achieved using propranolol. (I) are of low toxicity. LD50 are 6,800-121,000 times greater than the ED50. (I) therefore have a wider therapeutic index than propranol has (only 1,030). Suitable unit doses of (I) are 1-100 (pref. 3-50) mg for humans.
-
公开(公告)号:DE3135250A1
公开(公告)日:1983-03-17
申请号:DE3135250
申请日:1981-09-05
Applicant: BASF AG
IPC: A61K31/425 , A61K31/428 , A61P37/08 , C07D277/60 , C07D277/82 , C07D277/84
Abstract: Thiazolyloxamic acids and their derivatives of the general formula I processes for their preparation, and pharmaceutical formulations which contain these compounds and are useful as drugs for treating allergic disorders.
-
公开(公告)号:DE3006809A1
公开(公告)日:1981-09-24
申请号:DE3006809
申请日:1980-02-23
Applicant: BASF AG
Inventor: SCHLECKER RAINER DIPL CHEM DR , FRICKEL FRITZ-FRIEDER DIPL CHE , FRANKE ALBRECHT DIPL CHEM DR , LENKE DIETER PROF DR , GRIES JOSEF DR MED
IPC: A61K31/42 , A61P9/00 , A61P9/12 , A61P25/02 , C07D261/08 , C07D261/10 , C07D261/18 , C07F9/653 , C07D261/06
-
公开(公告)号:DE3146599A1
公开(公告)日:1983-07-07
申请号:DE3146599
申请日:1981-11-25
Applicant: BASF AG
IPC: A61K31/505 , A61P37/08 , C07D239/95 , C07D487/04 , C07D491/04 , C07D491/14 , C07D491/147
Abstract: 1,2,4-Triazolo[1,5-c]-quinazolinones of the general formula I (I) and their pharmaceutically tolerated salts, processes for their preparation and pharmaceutical formulations which contain these compounds and are useful drugs in the treatment of allergic disorders.
-
公开(公告)号:DE3112164A1
公开(公告)日:1982-10-14
申请号:DE3112164
申请日:1981-03-27
Applicant: BASF AG
Inventor: SCHLECKER RAINER DIPL CHEM DR , FRANKE ALBRECHT DIPL CHEM DR , HAGEN HELMUT DIPL ING DR , FRIEDRICH LUDWIG DR , LENKE DIETER PROF DR
IPC: C07D275/04 , A61K31/425
Abstract: The present invention relates to benzisothiazolyloxamide esters and the acids on which they are based and their salts, processes for their preparation and pharmaceutical preparations containing these compounds, which preparations can be used as medicaments in the treatment of allergic disorders.
-
-
-
-